The CDMO is looking to mitigate supply chain risks by integrating modularization and standardization into its network, offering customers flexibility and scalability.
The expanded agreement between BMS and the Indian CRDMO broadens integrated discovery, development, and manufacturing services across the drug lifecycle.
